The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

Harvard Medical School scientists have identified a key protein in the human immune system that drives inflammatory and ...

When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...

Q4 2024 Earnings Call Transcript March 31, 2025 Omeros Corporation beats earnings expectations. Reported EPS is $-0.54, ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

If you are contemplating the types of plants and hardscape design to install in your yard, consider these recommendations ...

Shiba Inu (SHIB) continues to dominate conversations in the crypto world with its characteristic volatility. A recent market ...

Officials with the Flyway development in Webster are continuing to build out the destination with a pair of projects meant to ...